Not yet recruiting NCT06260046
Effect of Sufentanil on the Postoperative Pain
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Sufentanil, Remifentanil.
- Who it may be relevant to
- Registry conditions: Postoperative Pain, Acute. Basic parameters: from 19 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Analgesic Effect of Intraoperative Sufentanil on Postoperative Pain in Patients Undergoing Robot-assisted Nephrectomy: a Prospective Randomized Controlled Trial
Overview
This study is a randomized, controlled trial. A total of 48 patients will be randomized to receive sufentanil or remifentanil during robot-assisted nephrectomy surgery.
Interventions
- Drug Sufentanil
Induction: sufentanil TCI 0.3 ng/ml Maintenance: sufentanil TCI 0.05-0.5 ng/ml - Drug Remifentanil
Induction: remifentanil TCI 3 ng/ml Maintenance: remifentanil TCI 0.5-5 ng/ml
Primary outcome measures
- opioid consumption [Time frame: During post-anesthesia care unit(PACU) stay, until 1 hour]
Secondary outcome measures (4)
- Richmond Agitation-Sedation scale [Time frame: During post-anesthesia care unit(PACU) stay, until 1 hour]
- Incidence of postoperative nausea and vomiting [Time frame: During post-anesthesia care unit(PACU) stay, until 1 hour]
- Number of patients who administered antiemetics [Time frame: During post-anesthesia care unit(PACU) stay, until 1 hour]
- Pain score [Time frame: immediately after surgery, 15minutes, 30minutes, 60minutes after surgery]
Eligibility criteria
Inclusion criteria
- Patients who undergo elective robot-assisted nephrectomy surgery
- American Society of Anesthesiologists grade 1,2,3
- Age > 18 years old
Exclusion criteria
- Refuse to participate to the study
- Allergic history of opioid
- chronic pain
- opioid user before surgery
- MAO inhibitor user
- Severe respiratory insufficiency
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Prevention
Study locations
South Korea · 1 center
- Seoul National University Bundang Hospital — Seongnam
Identifiers
NCT: NCT06260046 · Robot Nx-SFTN